X. Baraliakos

S. Ruetten, M. Komp, G. Godolias, 2018, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

Surgical treatment of cervical subaxial intraspinal extradural cysts using a full-endoscopic uniportal posterior approach

S. Ruetten, M. Komp, G. Godolias, 2018, Journal of orthopaedic surgery.

Full-endoscopic Uniportal Odontoidectomy and Decompression of the Anterior Cervicomedullary Junction Using the Retropharyngeal Approach

S. Ruetten, M. Komp, H. Merk, 2018, Spine.

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Andreas Krause, H. Zeidler, G. Burmester, 2007, Annals of the rheumatic diseases.

Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.

R. Landewé, M. Østergaard, J. Braun, 2005, The Journal of rheumatology.

A. Deodhar, P. Mease, I. McInnes, 2019, Arthritis Research & Therapy.

The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study

J. Braun, U. Kiltz, M. Bollow, 2012, Annals of the rheumatic diseases.

OP0001 Effect of Secukinumab, An Interleukin-17a Inhibitor, on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of The Phase 3 Study, Measure 1

A. Deodhar, J. Braun, J. Sieper, 2016 .

Striking sex differences in magnetic resonance imaging findings in the sacroiliac joints in the population

R. Bülow, A. Richter, X. Baraliakos, 2022, Arthritis Research & Therapy.

Magnesium therapy in borderline hypertension

A. Mitchell, K. Kisters, R. Hunger, 2012 .

POS1078 COMPARISON OF PATIENTS WITH AXIAL PsA AND PATIENTS WITH axSpA AND CONCOMITANT PSORIASIS

G. Schett, A. Regierer, H. Lorenz, 2022, Annals of the Rheumatic Diseases.

Limited role of gadolinium to detect active sacroiliitis on MRI in juvenile spondyloarthritis

J. Jaremko, K. Verstraete, J. Dehoorne, 2015, Skeletal Radiology.

OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY

M. Dougados, D. M. van der Heijde, L. Gensler, 2022, Annals of the Rheumatic Diseases.

[Spondyloarthritis - the novel concept. An introduction to the diagnosis and treatment of axial spondyloarthritis].

J. Braun, U. Kiltz, X. Baraliakos, 2012, Deutsche Medizinische Wochenschrift.

SAT0268 Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 years in patients with active ankylosing spondylitis

P. Emery, Z. Tallóczy, J. Braun, 2018, Saturday, 16 JUNE 2018.

OP0243 Prevalence of inflammatory and chronic changes suggestive of axial spondyloarthritis in magnetic resonance images of the axial skeleton in individuals <45 years in the general population as part of a large community study (SHIP)

D. Feldmann, J. Braun, C. Schmidt, 2018, FRIDAY, 15 JUNE 2018.

FRI0396 Which Is The Most Reliable Imaging Method for Detection of Structural Changes in The Sacroiliac Joints of Patients with Ankylosing Spondylitis? A Cross-Sectional Study Comparing MRI, CT and Conventional Radiographs

J. Braun, F. Huang, F. Hoffmann, 2016 .

THU0233 Secukinumab Reduces Sacroiliac Joint and Spinal Inflammation in Patients with Ankylosing Spondylitis: MRI Data from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study (MEASURE 1)

J. Braun, J. Sieper, H. Richards, 2015 .

ASAS Recommendations for Requesting and Reporting Imaging Examinations in Patients with Suspected Axial Spondyloarthritis

D. Poddubnyy, T. Diekhoff, X. Baraliakos, 2022, Seminars in Musculoskeletal Radiology.

Treatment overview of axial spondyloarthritis in 2023.

U. Kiltz, X. Baraliakos, A. Ciurea, 2023, Best practice & research. Clinical rheumatology.

OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY

D. M. van der Heijde, L. Gensler, P. Pertel, 2023, Annals of the Rheumatic Diseases.

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab

J. Braun, J. Braun, J. Brandt, 2005, Arthritis Research & Therapy.

[Development of quality standards for patients with axial spondyloarthritis for use in Germany].

U. Syrbe, H. Schulze-Koops, J. Braun, 2021, Zeitschrift fur Rheumatologie.

Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver

U. Kiltz, X. Baraliakos, X. Baraliakos, 2022 .

OP0242 Fatty lesions detected on mri scans in patients with ankylosing spondylitis are based on the deposition of fat in the vertebral bone marrow

G. Schett, J. Braun, J. Braun, 2018, FRIDAY, 15 JUNE 2018.

SAT0430 The relationship between exosomal MIRNA21-5P and ankylosing spondylitis

J. Braun, Yanyan Wang, F. Hoffmann, 2017 .

THU0262 Sclerostin does not predict radiographic progression in patients on anti-tnf therapy – new results from the european ankylosing spondylitis (AS) infliximab cohort (EASIC)

M. Dougados, R. Landewé, P. Emery, 2013 .

The ASAS-OMERACT core domain set for axial spondyloarthritis.

M. Dougados, B. Shea, A. Boonen, 2021, Seminars in arthritis and rheumatism.

POS0531 ABATACEPT DELAYS THE DEVELOPMENT OF RA– CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS

E. Naredo, J. Strunk, G. Schett, 2022, Annals of the Rheumatic Diseases.

Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis

R. Gay, S. Gay, J. Braun, 2008, Annals of the rheumatic diseases.